1. Home
  2. AMPH vs GOOS Comparison

AMPH vs GOOS Comparison

Compare AMPH & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • GOOS
  • Stock Information
  • Founded
  • AMPH 1996
  • GOOS 1957
  • Country
  • AMPH United States
  • GOOS Canada
  • Employees
  • AMPH N/A
  • GOOS N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • GOOS
  • Sector
  • AMPH Health Care
  • GOOS
  • Exchange
  • AMPH Nasdaq
  • GOOS Nasdaq
  • Market Cap
  • AMPH 1.1B
  • GOOS 1.1B
  • IPO Year
  • AMPH 2014
  • GOOS 2017
  • Fundamental
  • Price
  • AMPH $21.67
  • GOOS $13.05
  • Analyst Decision
  • AMPH Hold
  • GOOS Sell
  • Analyst Count
  • AMPH 5
  • GOOS 4
  • Target Price
  • AMPH $38.00
  • GOOS $11.25
  • AVG Volume (30 Days)
  • AMPH 462.5K
  • GOOS 1.3M
  • Earning Date
  • AMPH 08-07-2025
  • GOOS 07-31-2025
  • Dividend Yield
  • AMPH N/A
  • GOOS N/A
  • EPS Growth
  • AMPH N/A
  • GOOS 70.17
  • EPS
  • AMPH 2.77
  • GOOS 0.68
  • Revenue
  • AMPH $730,659,000.00
  • GOOS $943,742,214.00
  • Revenue This Year
  • AMPH $0.92
  • GOOS $4.27
  • Revenue Next Year
  • AMPH $5.55
  • GOOS $5.83
  • P/E Ratio
  • AMPH $7.84
  • GOOS $20.07
  • Revenue Growth
  • AMPH 8.05
  • GOOS 1.09
  • 52 Week Low
  • AMPH $20.43
  • GOOS $6.73
  • 52 Week High
  • AMPH $53.96
  • GOOS $15.43
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 41.15
  • GOOS 48.67
  • Support Level
  • AMPH $20.43
  • GOOS $13.76
  • Resistance Level
  • AMPH $22.90
  • GOOS $15.43
  • Average True Range (ATR)
  • AMPH 0.73
  • GOOS 0.58
  • MACD
  • AMPH 0.15
  • GOOS -0.13
  • Stochastic Oscillator
  • AMPH 50.20
  • GOOS 3.84

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.

Share on Social Networks: